期刊文献+

miR-34a在乳腺癌中的表达及其临床病理学意义 被引量:3

Expression of miR-34a in Breast Cancer and Its Clinicopathological Significance
下载PDF
导出
摘要 目的探讨外周血中微小RNA-34a(miR-34a)在乳腺癌组织中的表达及其临床病理学意义。方法选取乳腺癌组织标本80例(癌组织)、40例癌旁组织标本(癌旁组织),应用RT-PCR技术检测两组标本中的miR-34a表达水平,采用原位杂交方法检测miR-34a的表达,分析不同miR-34a表达与乳腺癌患者临床病理学特征的关系。结果乳腺癌组织中的miR-34a表达水平显著的低于癌旁组织,差异具有统计学意义(P<0.05);乳腺癌组织中的miR-34a表达水平与患者的TNM分期、浸润深度、淋巴结转移具有显著的相关性(P<0.05);乳腺癌组织中的miR-34a表达水平与患者的年龄、肿瘤直径、分化程度、肿瘤类型、ER表达、PR表达的情况无显著关系(P>0.05);低表达miR-34a乳腺癌患者随访60个月生存21例(46.67%)、失访3例,高表达miR-34a乳腺癌患者生存20例(64.52%)、失访1例,两组生存率比较差异无统计学意义(χ2=2.354,P=0.125>0.05)。低表达miR-34a乳腺癌患者生存时间低于高表达miR-34a乳腺癌患者[Log Rank(Mantel-Cox)=3.928,P=0.047<0.05]。结论乳腺癌组织中miR-34a低表达,并且与患者TNM分期、浸润深度、淋巴结转移、不良预后有关。 Objective To investigate the expression of RNA-34a(miR-34a)in peripheral blood and its clinicopathological significance in breast cancer.Methods The expression of microRNA-34a in breast cancer tissues from 80 breast cancer patients,40 cases of paracancerous tissues were detected by RT-PCR and in situ hybridization.The relationship between the expression of microRNA-34a and clinicopathological characteristics of breast cancer patients was analyzed.Results The expression of miR-34a in breast cancer was significantly lower than that of the adjacent tissues,the difference was statistically significant(P<0.05);breast cancer tissues and the expression level of miR-34a in patients were significantly correlated with TNM stage,depth of invasion,and lymph node metastasis(P<0.05);breast cancer tissue miR-34a levels in patients had no significant relationship with the age,the diameter of tumor,differentiation,tumor type,ER expression,PR expression(P>0.05);the follow-up of miR-34a breast cancer patients with low expression 60 months survival was 21 cases(46.67%),3 cases were lost,the high expression of miR-34a in breast cancer survival in 20 cases(64.52%),1 cases were lost,two group survival rate had no significant difference(χ2=2.354,P=0.125>0.05).The survival time of breast cancer patients with low expression of miR-34a was lower than that with high expression of miR-34a(Log Rank(Mantel-Cox)=3.928,P=0.047<0.05).Conclusion Low expression of miR-34a in breast cancer tissues is associated with TNM stage,depth of invasion,lymph node metastasis,and poor prognosis.
作者 岳会珠 王桂菊 齐红双 许丽 YUE Huizhu;WANG Guiju;QI Hongshuang(Nanyang Nanshi Hospital,Nanyang,473000)
出处 《实用癌症杂志》 2019年第9期1417-1420,共4页 The Practical Journal of Cancer
关键词 微小RNA-34a 乳腺癌 临床病理学特征 Minimal RNA-34a Breast cancer Clinicopathological features
  • 相关文献

参考文献10

二级参考文献66

  • 1Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
  • 2Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer[J]. Cancer Res, 2005, 65(16):7065-7070.
  • 3Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature, 2007, 449(7163):682-688.
  • 4Selcuklu SD, Donoghue MT, Rehmet K, et al. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells[J]. J Biol Chem, 287(35):29516-29528.
  • 5Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis[J]. Nature, 2008, 451(7175):147-152.
  • 6Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1[J]. Nat Cell Biol, 2008, 10(5):593-601.
  • 7Wang H, Tan G, Dong L, et al. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer[J]. PLoS One, 2012, 7(4):e34210. doi: 10.1371/journal.pone.0034210.
  • 8Kastl L, Brown I, Schofield AC. miRNA-34a is associated with docetaxel resistance in human breast cancer cells[J]. Breast Cancer Res Treat, 2012, 131(2): 445-454.
  • 9Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection[J]. Nat Rev Cancer, 2005, 5(11): 845-856.
  • 10Cekaite L, Rantala JK, Bruun J, et al. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer[J]. Neoplasia, 2012, 14(9):868-879.

共引文献53

同被引文献29

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部